Using TRACE4BUS for breast biopsy classification
Part of Cancer, Skin clinical trials.
This study is testing a computer tool called TRACE4BUS to help classify breast ultrasound images and biopsy results. It looks at past biopsy samples (retrospective part) and also enrolls new patients (prospective part) to see if the tool can improve accuracy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had an ultrasound-guided breast biopsy
- If your biopsy was B3 (uncertain), you need either a follow-up surgery or at least 12 months of clinical follow-up
- You are between 18 and 89 years old
- For the prospective part, you must sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a scanner (Histolog®) that checks the edges of removed breast tissue during surgery to make sure all cancer is removed. The goal is to reduce the need for a second surgery.
This trial tests a new high-resolution PET/CT scanner used during breast-conserving surgery to check if all cancer has been removed. It aims to reduce the need for repeat surgeries by giving surgeons real-time feedback on tumor margins.
This study tests a new type of ultrasound imaging called super-resolution ultrasound that creates very detailed pictures of breast cancer. Researchers will use it to track how well chemotherapy is working before surgery, which may help doctors plan better treatment.
This study is testing a research tool that may help doctors choose the best treatment for people with advanced triple-negative breast cancer. You will have a biopsy and blood draw to help see how the tool works.
This study looks at whether features seen on ultrasound and mammogram can help identify the molecular type of breast cancer. It may help patients understand their cancer better without extra tests.
This trial uses ultrasound to see if an AI tool can better find small markers placed in the breast during a biopsy. It might help improve follow-up care and make future procedures more precise.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.